INS and Obesity: Nonetheless, Jordan et al. investigated the effects of combined sacubitril/valsartan treatment in hypertensive patients with obesity, indicating remarkably improved insulin sensitivity and increased lipolysis of abdominal subcutaneous adipose tissue but did not affect whole-body lipolysis [138].